|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
7.875 +0.010 (+0.127%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 417,104 | -14.457% | 487,596 | 380,131 | 540,707 | 571,392 |
| Cost of Sales | (147,786) | -7.906% | (160,473) | -- | -- | -- |
| Gross Profit | 269,318 | -17.671% | 327,124 | -- | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,215) | -90.823% | (35,034) | (6,353) | (7,582) | (12,817) | |
| Profit / (Loss) on Disposal | -- | -- | 4 | 39 | -- | 25 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 133,457 | 4.826% | 127,313 | 83,070 | 138,537 | 172,397 | |
| Taxation | (13,518) | 5.353% | (12,831) | (4,109) | (12,552) | (15,415) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 18 | -- | (12) | 65 | 92 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 119,957 | 4.794% | 114,469 | 79,026 | 126,077 | 156,982 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,404 | -- | (6,743) | (9,012) | (4,994) | (5,778) |
| Depreciation & Amortisation | 21,026 | 5.068% | 20,011 | 18,650 | 16,176 | 13,287 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 31.000 | 3.333% | 30.000 | 21.000 | 33.000 | 41.000 |
| DPS (cts) | 13.000 | -- | 0.000 | 8.300 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 41.935% | -- | -- | 39.524% | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 7.975 | -- | 7.608 | 7.346 | 7.106 | 6.704 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 119,957 |
| %Change | 4.794% |
| EPS / (LPS) | RMB 0.310 |
| NBV Per Share (¥) | RMB 7.975 |